BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bao S, Zheng H, Ye J, Huang H, Zhou B, Yao Q, Lin G, Zhang H, Kou L, Chen R. Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. Front Pharmacol 2021;12:625084. [PMID: 33815107 DOI: 10.3389/fphar.2021.625084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ercin E, Kecel-Gunduz S, Gok B, Aydin T, Budama-Kilinc Y, Kartal M. Laurus nobilis L. Essential Oil-Loaded PLGA as a Nanoformulation Candidate for Cancer Treatment. Molecules 2022;27:1899. [PMID: 35335262 DOI: 10.3390/molecules27061899] [Reference Citation Analysis]
2 Wang X, Wu C, Liu S, Peng D. Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives. Drug Deliv 2022;29:1370-83. [PMID: 35532094 DOI: 10.1080/10717544.2022.2069881] [Reference Citation Analysis]
3 Chen R, Zhai Y, Sun L, Wang Z, Xia X, Yao Q, Kou L. Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.02.003] [Reference Citation Analysis]
4 Tiron A, Stan CS, Luta G, Uritu CM, Vacarean-Trandafir IC, Stanciu GD, Coroaba A, Tiron CE. Manganese-Doped N-Hydroxyphthalimide-Derived Carbon Dots-Theranostics Applications in Experimental Breast Cancer Models. Pharmaceutics 2021;13:1982. [PMID: 34834397 DOI: 10.3390/pharmaceutics13111982] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rasouli M, Fallah N, Bekeschus S. Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication. Oxid Med Cell Longev 2021;2021:2990326. [PMID: 34745414 DOI: 10.1155/2021/2990326] [Reference Citation Analysis]
6 Lin SR, Yeh HL, Liu YN. Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation. Cancers (Basel) 2021;13:3452. [PMID: 34298665 DOI: 10.3390/cancers13143452] [Reference Citation Analysis]
7 Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 2021;14:85. [PMID: 34059100 DOI: 10.1186/s13045-021-01096-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]